JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 23, 2007; DOI: 10.1124/jpet.107.125047


0022-3565/07/3232-458-468$20.00
JPET 323:458-468, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.125047v1
jpet.107.125047v2
323/2/458    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gasior, M.
Right arrow Articles by Rogawski, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gasior, M.
Right arrow Articles by Rogawski, M. A.

NEUROPHARMACOLOGY

Prolonged Attenuation of Amygdala-Kindled Seizure Measures in Rats by Convection-Enhanced Delivery of the N-Type Calcium Channel Antagonists {omega}-Conotoxin GVIA and {omega}-Conotoxin MVIIA

Maciej Gasior1, Natalie A. White, and Michael A. Rogawski

Epilepsy Research Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (M.G., N.A.W., M.A.R.); and Department of Neurology, University of California, Davis, Sacramento, California (M.A.R.)

Convection-enhanced delivery (CED) permits the homogeneous distribution of therapeutic agents throughout localized regions of the brain parenchyma without causing tissue damage as occurs with bolus injection. Here, we examined whether CED infusion of the N-type calcium channel antagonists {omega}-conotoxin GVIA ({omega}-CTX-G) and {omega}-conotoxin MVIIA ({omega}-CTX-M) can attenuate kindling measures in fully amygdala-kindled rats. Rats were implanted with a combination infusion cannula-stimulating electrode assembly into the right basolateral amygdala. Fully kindled animals received infusions of vehicle, {omega}-CTX-G (0.005, 0.05, and 0.5 nmol), {omega}-CTX-M (0.05, 0.15, and 0.5 nmol), proteolytically inactivated {omega}-CTX-M (0.5 nmol), or carbamazepine (500 nmol) into the stimulation site. CED of {omega}-CTX-G and {omega}-CTX-M over a 20-min period resulted in a dose-dependent increase in the afterdischarge threshold and a decrease in the afterdischarge duration and behavioral seizure score and duration during a period of 20 min to 1 week after the infusion, indicating an inhibitory effect on the triggering and expression of kindled seizures. The protective effects of {omega}-conotoxins reached a maximum at 48 h postinfusion, and then they gradually resolved over the next 5 days. In contrast, carbamazepine was active at 20 min but not at 24 h after the infusion, whereas CED of vehicle or inactivated {omega}-CTX-M had no effect. Except for transient tremor in some rats receiving the highest toxin doses, no adverse effects were observed. These results indicate that local CED of high-molecular-weight presynaptic N-type calcium channel blockers can produce long-lasting inhibition of brain excitability and that they may provide prolonged seizure protection in focal seizure disorders.


Received for publication May 7, 2007
Accepted August 22, 2007.

Address correspondence to: Dr. Michael A. Rogawski, Department of Neurology, 4860 Y St., Suite 3700, University of California, Davis, Sacramento, CA 95817. E-mail: rogawski{at}ucdavis.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.